American Journal of Cardiology
Volume 101, Issue 7 , Pages 937-940, 1 April 2008

Changes in Left Anterior Descending Coronary Artery Wall Thickness Detected by High Resolution Transthoracic Echocardiography

Cardiac Services, Flinders Medical Centre/Flinders University, Bedford Park, South Australia, Australia.

Received 7 September 2006; received in revised form 13 November 2006; accepted 13 November 2006. published online 29 January 2008.

Recently, it has been demonstrated that high-resolution transthoracic echocardiography (HRTTE) is able to detect differences in the wall thickness of the left anterior descending coronary artery (LAD) between patients with coronary artery disease (CAD) and normal volunteers. The aim of this study was to further validate this technique. One hundred ten volunteers, 58 patients with angiographically proved CAD and 52 control subjects, underwent assessments of their LADs using HRTTE. Anterior and posterior wall thicknesses differed between subjects in the CAD group and controls (1.9 ± 0.6 vs 1.2 ± 0.3 mm, p <0.001, and 1.8 ± 0.5 vs 1.2 ± 0.3 mm, p <0.001, respectively). External LAD diameter was also greater in subjects in the CAD group compared with controls (5.2 ± 1.9 vs 4.4 ± 0.9 mm, respectively, p = 0.01). However, there was no difference in luminal diameter between subjects in the CAD group and the controls (1.9 ± 0.9 vs 2.1 ± 0.8 mm, respectively, p = 0.3). In conclusion, HRTTE demonstrated that LAD wall thicknesses and external diameters in patients with CAD were significantly larger than in normal volunteers. Luminal diameter, however, was maintained in the 2 groups, indicating that subjects in the CAD group had undergone positive remodeling at the site measured. This objectively visualized evidence of coronary atherosclerosis with HRTTE would likely be undetected during coronary angiography.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr. Joseph is supported by a Cardiovascular Lipid Grant from Pfizer Australia, Sydney, Australia.

PII: S0002-9149(07)02318-1

doi:10.1016/j.amjcard.2007.11.053

American Journal of Cardiology
Volume 101, Issue 7 , Pages 937-940, 1 April 2008